Indonesian Controversial Health Law Draft: Impact on Tobacco Industry

Regulations by 2FIRSTS.ai
Dec.28.2023
Indonesian Controversial Health Law Draft: Impact on Tobacco Industry
Indonesia's proposed health regulation, which includes measures on tobacco products, has sparked controversy amid concerns over economic losses.

According to a report by Indonesian media Kompas.com on December 28th, the Indonesian government is currently drafting a government regulation on health in collaboration with the Ministry of Health. This regulation is being developed as a derivative legislation to Law No. 17 on health.

 

The main issues in health regulations include the management of healthcare workers, the integration of primary healthcare services, healthcare for non-communicable diseases, protection against addictive substances in tobacco and e-cigarette products, emergency response to abnormal conditions and epidemics, healthcare funding, community participation, and governance in terms of guidance and supervision.

 

One of the main aspects covered in the issue relates to the regulation of addictive substances, including tobacco products and e-cigarettes. While this regulation aims to improve public health standards, its draft has sparked controversy.

 

The tobacco industry is a labor-intensive sector that provides numerous benefits to the Indonesian economy. Critics argue that the measures encompassed in this regulation discriminate against the tobacco industry (IHT) and its products.

 

According to data from the Ministry of Industry of Indonesia (Kemenperin), the tobacco industry employed a total of 5.98 million workers in 2018, including 4.28 million in the manufacturing and distribution sectors and 1.7 million in the cultivation sector. This industry also made a significant contribution to the country's income. Through exports, the tobacco processing industry contributed billions of dollars to Indonesia.

 

In addition, the Indonesian tobacco industry (IHT) contributed a total of 21.8 trillion Indonesian rupiah and 18.88 trillion Indonesian rupiah to the nation through tobacco taxes (CHT) in 2022 and 2021 respectively.

 

The Indonesian Institute for Economic and Financial Development (Indef) released a research report on December 20th in Jakarta, revealing that if the health bill is approved, it could potentially result in a loss of up to 10.3 trillion rupees (approximately 877.7 billion RMB) for the country.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.

MGH Study: Varenicline Boosts Young Adults’ E-Cigarette Quit Rates by 50%
MGH Study: Varenicline Boosts Young Adults’ E-Cigarette Quit Rates by 50%
A study by Massachusetts General Hospital found that the oral smoking cessation drug varenicline significantly improves e-cigarette quit rates among young people aged 16 to 25. In a 12-week trial, 50% of participants in the varenicline group successfully quit vaping, compared to just 14% in the placebo group. After six months, 28% of those in the treatment group remained vape-free.
Apr.24 by 2FIRSTS.ai
Eco-Friendly Vape Brand No Saint Launches in 500 UK Stores with Sustainable Products and Age Verification
Eco-Friendly Vape Brand No Saint Launches in 500 UK Stores with Sustainable Products and Age Verification
The eco-friendly vape brand No Saint has launched in the UK, entering 500 retail stores. The products emphasize material safety and age restrictions, with flavors designed for a more mature palate. The founder has raised $50 million for the brand.
May.06 by 2FIRSTS.ai
Poland Advances New Tobacco Control Rules: Comprehensive Ban on Sales of Nicotine Alternatives to Minors
Poland Advances New Tobacco Control Rules: Comprehensive Ban on Sales of Nicotine Alternatives to Minors
The Polish Senate plans to expand restrictions on e-cigarette sales by banning purchases by minors and prohibiting the use of nicotine-free e-cigarettes in public places.
Jun.11 by 2FIRSTS.ai
Baltimore, U.S., Targets Philip Morris Over ZYN Marketing to Youth
Baltimore, U.S., Targets Philip Morris Over ZYN Marketing to Youth
Baltimore city officials have filed a lawsuit against Philip Morris International, Swedish Match North America, and Swedish Match USA, accusing the companies of targeting minors in marketing their ZYN nicotine pouches. PMI said it had not yet received the complaint and stressed that its products are marketed exclusively to adults aged 21 and over.
May.12 by 2FIRSTS.ai
U.S. ITC Reopens PAX Labs Case Against STIIIZY, ALD; Domestic Industry Status at Center of Dispute
U.S. ITC Reopens PAX Labs Case Against STIIIZY, ALD; Domestic Industry Status at Center of Dispute
The U.S. International Trade Commission (ITC) has announced a partial review of a key ruling in PAX Labs' patent infringement case against STIIIZY and ALD, focusing on whether the economic prong of the "domestic industry" requirement was properly assessed. While the commission previously found some of PAX's patents valid and infringed, it ruled that PAX had not demonstrated sufficient U.S. economic investment to establish a domestic industry, and therefore did not find a violation.
May.20 by 2FIRSTS.ai
Korea's 2025 Tobacco Control Campaign Targets Youth Vaping
Korea's 2025 Tobacco Control Campaign Targets Youth Vaping
Korea's Ministry of Health and Welfare, in collaboration with the Health Promotion and Development Institute (HPDI), will launch its first 2025 tobacco control campaign on April 24, prioritizing efforts to curb youth vaping. Additional campaigns targeting adult smokers are slated for release later this year.
Apr.24 by 2FIRSTS.ai